Signaturefd, LLC Sorrento Therapeutics, Inc. Transaction History

Signaturefd, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 27, 2023	BUY	$0.74 - $1.83 $421 - $1,041	569 New	569 $0
Q2 2022 Aug 10, 2022	SELL	$1.24 - $2.33 $2,137 - $4,016	-1,724 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$2.0 - $4.9 $3,448 - $8,447	1,724 New	1,724 $4,000
Q4 2021 Jan 25, 2022	SELL	$4.65 - $7.23 $888 - $1,380	-191 Closed	0 $0
Q3 2021 Oct 28, 2021	BUY	$7.41 - $10.99 $1,415 - $2,099	191 New	191 $1,000
Q2 2021 Jul 26, 2021	SELL	$6.35 - $10.0 $3,238 - $5,100	-510 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$7.03 - $16.51 $3,585 - $8,420	510 New	510 $4,000
Q3 2020 Nov 03, 2020	SELL	$6.17 - $18.82 $2,832 - $8,638	-459 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$1.73 - $6.76 $794 - $3,102	459 New	459 $3,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.